Pfizer CEO Albert Bourla sits down with CNBC’s Andrew Ross Sorkin at the 2022 World Economic Forum to discuss Covid-19 cases in the U.S. and the company’s move to offer its drugs at cost in low-income countries.
Pfizer to provide patent-protected medicines at cost in low-income countries
Tweet on Twitter
Share on Facebook
Pinterest
